FLUNIXIN MEGLUMINE powder
Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
Preparatomtale
(SPC)
16-12-2021
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
FLUNIXIN MEGLUMINE (UNII: 8Y3JK0JW3U) (FLUNIXIN - UNII:356IB1O400)
Tilgjengelig fra:
Qilu SYNVA Pharmaceutical Co., Ltd.
Administreringsrute:
NOT APPLICABLE
Resept typen:
BULK INGREDIENT -
Autorisasjon status:
bulk ingredient
Preparatomtale
FLUNIXIN MEGLUMINE- FLUNIXIN MEGLUMINE POWDER
QILU SYNVA PHARMACEUTICAL CO., LTD.
----------
FLUNIXIN MEGLUMINE
flunixin meglumine powder
PRODUCT INFORMATION
PRODUCT TYPE
ITEM CODE (SOURCE)
NDC:49553-4661
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
FLUNIXIN MEGLUMINE (UNII: 8Y3JK0JW3U) (FLUNIXIN - UNII:356IB1O400)
FLUNIXIN MEGLUMINE
25 kg in 25 kg
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1 NDC:49553-4661-1
25 kg in 1 DRUM
Qilu SYNVA Pharmaceutical Co., Ltd.
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
bulk ingredient
12/16/2021
LABELER -
Qilu SYNVA Pharmaceutical Co., Ltd. (421272539)
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
Qilu SYNVA Pharmaceutical Co., Ltd.
421272539
api manufacture
Revised: 12/2021
Les hele dokumentet
